Oxford University's vaccine could be up to 90 per cent effective, data from phase III trials shows today. With the UK government ordering 100 million doses of the jab, could it mean a return to normality is on the horizon? Katy Balls speaks to Fraser Nelson and James Forsyth.Become a Spectator subscriber today to access this podcast without adverts. Go to spectator.co.uk/adfree to find out more.For more Spectator podcasts, go to spectator.co.uk/podcasts.Contact us: [email protected] Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related